Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Tilkin

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Transplantation|March 1, 1986
A possible predictive test for graft-versus-host disease in bone marrow graft recipients: the mixed-epidermal cell-lymphocyte reactionM Bagot, C Cordonnier, A F Tilkin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 1, 1987
Autoreactive T cell clones of MHC class II specificities are produced during responses against foreign antigens in manA F Tilkin, J Michon, D Juy, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 1, 1978
Transplantable IgD immunoglobulin-secreting tumors in ratH Bazin, A Beckers, G Urbain-Vansanten, et al.
Transplantation|August 1, 1987
Reconstitution of cytotoxic T lymphocyte activity following allogeneic bone marrow transplantation in manA F Tilkin, M Bagot, F Dreyfus, et al.
International Immunology|February 1, 1995
Mutations in residue 61 of H-Ras p21 protein influence MHC class II presentationN Ngo-Giang-Huong, M Kayibanda, B Deprez, et al.
Cancer Gene Therapy|March 3, 2001
The expression of CD70 and CD80 by gene-modified tumor cells induces an antitumor response depending on the MHC statusV Douin-Echinard, S Bornes, P Rochaix, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|July 2, 2005
Geranylgeranyl transferase inhibition stimulates anti-melanoma immune response through MHC Class I and costimulatory molecule expressionA-F Tilkin-Mariamé, C Cormary, N Ferro, et al.
European Journal of Immunology|June 1, 1995
Primary proliferative T cell response to wild-type p53 protein in patients with breast cancerA F Tilkin, R Lubin, T Soussi, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Transplantation|March 1, 1986
A possible predictive test for graft-versus-host disease in bone marrow graft recipients: the mixed-epidermal cell-lymphocyte reactionM Bagot, C Cordonnier, A F Tilkin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 1, 1987
Autoreactive T cell clones of MHC class II specificities are produced during responses against foreign antigens in manA F Tilkin, J Michon, D Juy, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 1, 1978
Transplantable IgD immunoglobulin-secreting tumors in ratH Bazin, A Beckers, G Urbain-Vansanten, et al.
Transplantation|August 1, 1987
Reconstitution of cytotoxic T lymphocyte activity following allogeneic bone marrow transplantation in manA F Tilkin, M Bagot, F Dreyfus, et al.
International Immunology|February 1, 1995
Mutations in residue 61 of H-Ras p21 protein influence MHC class II presentationN Ngo-Giang-Huong, M Kayibanda, B Deprez, et al.
Cancer Gene Therapy|March 3, 2001
The expression of CD70 and CD80 by gene-modified tumor cells induces an antitumor response depending on the MHC statusV Douin-Echinard, S Bornes, P Rochaix, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|July 2, 2005
Geranylgeranyl transferase inhibition stimulates anti-melanoma immune response through MHC Class I and costimulatory molecule expressionA-F Tilkin-Mariamé, C Cormary, N Ferro, et al.
European Journal of Immunology|June 1, 1995
Primary proliferative T cell response to wild-type p53 protein in patients with breast cancerA F Tilkin, R Lubin, T Soussi, et al.
Pageof 2